Related Experiment Video
Updated: Oct 22, 2025

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
Biologic Therapies and Autoimmune Phenomena.
Alexandros A Drosos1, Eleftherios Pelechas1, Evripidis Kaltsonoudis1
1Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece.
Biologic medications, while effective for autoimmune rheumatic diseases, can paradoxically trigger new autoimmune phenomena. Early recognition of these adverse effects is crucial for accurate diagnosis and treatment.
Area of Science:
- Rheumatology
- Immunology
- Pharmacology
Background:
- Biologic medications represent a significant advancement in treating autoimmune rheumatic diseases.
- Despite their efficacy, recent reports indicate an increase in autoimmune phenomena and paradoxical inflammation associated with their use.
Purpose of the Study:
- To review the spectrum of potential adverse autoimmune manifestations linked to biologic medication use.
- To emphasize the importance of early recognition for timely diagnosis and management.
Main Methods:
- Literature review of reported cases and studies on biologic-induced autoimmunity.
- Analysis of the range and types of autoimmune phenomena observed.
Main Results:
- Biologic medications can induce a wide array of autoimmune responses, from autoantibody detection to severe systemic autoimmune diseases.
- These adverse effects can manifest as organ-specific or systemic conditions.
Conclusions:
- Physicians must be vigilant for potential autoimmune adverse effects of biologic therapies.
- Prompt identification of these phenomena is essential for appropriate patient care and treatment adjustment.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drug Products: Biologics, Biosimilars and Interchangeables
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics

